These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7825844)

  • 1. Eicosanoid biosynthesis and metabolism in myeloproliferative disorders.
    Patrono C; Ciabattoni G; Patrignani P; Rocca B; Landolfi R
    Ann N Y Acad Sci; 1994 Nov; 744():229-36. PubMed ID: 7825844
    [No Abstract]   [Full Text] [Related]  

  • 2. Normal vascular prostacyclin generation in patients with chronic myeloproliferative disorders.
    Cortelazzo S; Viero P; Morelli C; Barbui T; de Gaetano G
    Thromb Res; 1985 Jul; 39(1):139-41. PubMed ID: 3898466
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders.
    Breuer JH; Harsányi V; Solti V; Hollán SR
    Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B14-binding protein in polycythemia vera plasma.
    Hall CA; Finkler AE
    J Lab Clin Med; 1969 Jan; 73(1):60-9. PubMed ID: 5762165
    [No Abstract]   [Full Text] [Related]  

  • 5. [THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISEASES].
    DEGTIAREVA MM
    Probl Gematol Pereliv Krovi; 1963 Aug; 8():30-6. PubMed ID: 14091615
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE MYELOPROLIFERATIVE SYNDROME FROM THE VIEWPOINT OF CLINICAL HEMATOLOGISTS].
    KUNZ G
    Z Gesamte Inn Med; 1964 Dec; 19():SUPPL:194-7. PubMed ID: 14235899
    [No Abstract]   [Full Text] [Related]  

  • 7. [MYELOPROLIFERATIVE DISORDERS].
    MARCIACQ ALTAFULLA
    Arch Med Panamenos; 1963 Aug; 12():149-59. PubMed ID: 14164997
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term bone marrow cultures in polycythaemia vera and essential thrombocythaemia.
    Jantunen R; Juvonen E; Aimolahti A; Ruutu T
    Acta Haematol; 1996; 96(4):227-31. PubMed ID: 8922489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 beta and interleukin-6 in clonal versus reactive thrombocytosis.
    Sayinalp N; Haznedaroğlu IC; Ozdemir O; Ozcebe OI; Dündar S; Kirazli S
    Eur J Haematol; 1995 Nov; 55(5):339-40. PubMed ID: 7493683
    [No Abstract]   [Full Text] [Related]  

  • 10. Disordered eicosanoid formation in pregnancy-induced hypertension.
    Meagher EA; FitzGerald GA
    Circulation; 1993 Sep; 88(3):1324-33. PubMed ID: 8353893
    [No Abstract]   [Full Text] [Related]  

  • 11. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
    Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C
    Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE PLACE OF OSTEOMYELOSCLEROSIS AMONG THE MYELOPROLIFERATIVE DISEASES].
    STOBBE H
    Dtsch Gesundheitsw; 1965 Jan; 20():13-20. PubMed ID: 14265017
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erythropoietic rate measured by ferrokinetics].
    Montz R
    Nucl Med (Stuttg); 1970 Mar; 9(1):50-61. PubMed ID: 5505733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
    Eid J; Ebert RF; Gesell MS; Spivak JL
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases.
    Goetzl EJ; An S; Smith WL
    FASEB J; 1995 Aug; 9(11):1051-8. PubMed ID: 7649404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Development and Use of Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms.
    Hobbs GS; Rozelle S; Mullally A
    Hematol Oncol Clin North Am; 2017 Aug; 31(4):613-626. PubMed ID: 28673391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies and eicosanoids.
    Carreras LO; Maclouf J
    Lupus; 1994 Aug; 3(4):271-3. PubMed ID: 7804315
    [No Abstract]   [Full Text] [Related]  

  • 19. Intratracheal dosing with disodium cromoglycate inhibits late asthmatic response by attenuating eicosanoid production in guinea pigs.
    Nabe T; Yamamoto M; Suga M; Kohno S
    Eur J Pharmacol; 2004 Aug; 497(1):97-104. PubMed ID: 15321740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The myeloproliferative syndromes.
    Penington DG
    Med J Aust; 1974 Jul; 2(2):56-64. PubMed ID: 4416373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.